Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic

Naoyuki Hirata1, Michiaki Yamakage2

  • 1Department of Anesthesiology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo , Hokkaido, 060-8543, Japan. naohirata@mac.com.

Journal of Anesthesia
|September 5, 2020
PubMed

Insights

Anesthesiologists face challenges during the COVID-19 pandemic, as cardiovascular complications are common and increase mortality risk. Perioperative care must address both respiratory and cardiovascular issues in patients with or recovering from COVID-19.

Area of Science:

  • Anesthesiology
  • Cardiology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic presents significant challenges for anesthesiologists and perioperative care.
  • While airway management is a primary concern, cardiovascular complications are frequently observed in COVID-19 patients.
  • Patients with pre-existing cardiovascular disease (CVD) exhibit a higher mortality rate when infected with SARS-CoV-2.

Purpose of the Study:

  • To highlight the critical need for anesthesiologists to consider cardiovascular complications in COVID-19 patients.
  • To emphasize the importance of comprehensive perioperative management addressing both respiratory and circulatory status.

Main Methods:

  • Review of current COVID-19 data and previous studies on cardiovascular disease and mortality.
  • Analysis of the impact of anesthesia and surgery on immune function in patients with CVD.

Main Results:

  • Cardiovascular complications are common in COVID-19 patients, impacting prognosis.
  • Immune system dysregulation in CVD patients may influence COVID-19 outcomes.
  • Anesthesia and surgical procedures can alter immune responses.

Conclusions:

  • Anesthesiologists must prioritize cardiovascular assessment and management alongside respiratory care for COVID-19 patients.
  • Perioperative circulatory management is crucial for controlling disease progression in patients with suspected, diagnosed, or recovered COVID-19, especially those with CVD.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
165
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.7K
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
195
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
326
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132